UK Drug Discovery Series C+ Funding Rounds 2026
Every UK Series C+ Drug Discovery funding round filed in 2026, sourced direct from Companies House filings. Updated weekly.
UK Drug Discovery Series C+ Funding Rounds 2026
| Company | Raised | Round | Date |
|---|---|---|---|
| Centessa Pharmaceuticals | £574.8M | Series C Plus | 2026/03/13 |
| Solstice Oncology Uk | £22.1M | Series C Plus | 2026/03/11 |
| Myricx Pharma | £39.6M | Series C Plus | 2026/03/03 |
| Lightcast Discovery | £12.0M | Series C Plus | 2026/02/25 |
| Celadon Pharmaceuticals | £30k | Series C Plus | 2026/02/17 |
| Cristae Therapeutics | £333k | Series C Plus | 2026/01/21 |
More Drug Discovery funding
- UK Drug Discovery Funding Rounds 202659
- London Drug Discovery Funding Rounds 202613
- UK Drug Discovery Seed Funding Rounds 202612
- UK Drug Discovery Series A Funding Rounds 20268
- Cambridge Drug Discovery Funding Rounds 20267
- UK Drug Discovery Seed Funding Rounds25
- UK Drug Discovery Series A Funding Rounds22
- London Drug Discovery Funding Rounds19
- Cambridge Drug Discovery Funding Rounds12
- Oxford Drug Discovery Funding Rounds8
- UK Drug Discovery Series C+ Funding Rounds6
- UK Drug Discovery Series B Funding Rounds6
- Altrincham Drug Discovery Funding Rounds6